These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12050592)

  • 41. Highlighting the new advances in drug discovery and development.
    Taliani S; Da Settimo F
    ChemMedChem; 2008 Jan; 3(1):181-4. PubMed ID: 18022978
    [No Abstract]   [Full Text] [Related]  

  • 42. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemistry challenges in lead optimization: silicon isosteres in drug discovery.
    Showell GA; Mills JS
    Drug Discov Today; 2003 Jun; 8(12):551-6. PubMed ID: 12821303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural products to drugs: natural product derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does chemistry have a future in therapeutic innovations?
    Meunier B
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8702-6. PubMed ID: 22777842
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmaceutical analysis in a multidisciplinary development environment.
    Berridge JC
    J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():361-6. PubMed ID: 8098744
    [No Abstract]   [Full Text] [Related]  

  • 48. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Where will we get the next generation of medicinal chemists?
    Allen D
    Drug Discov Today; 2016 May; 21(5):704-6. PubMed ID: 27131748
    [No Abstract]   [Full Text] [Related]  

  • 50. Overview of chemical diversity.
    Triggle DJ
    Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 21971814
    [No Abstract]   [Full Text] [Related]  

  • 51. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 52. The importance of synthetic chemistry in the pharmaceutical industry.
    Campos KR; Coleman PJ; Alvarez JC; Dreher SD; Garbaccio RM; Terrett NK; Tillyer RD; Truppo MD; Parmee ER
    Science; 2019 Jan; 363(6424):. PubMed ID: 30655413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical genomics versus orthodox drug development.
    Szymkowski DE
    Drug Discov Today; 2003 Feb; 8(4):157-9. PubMed ID: 12581708
    [No Abstract]   [Full Text] [Related]  

  • 54. Fragmentary solutions. Astex therapeutics puts the pieces together.
    Wolfson W
    Chem Biol; 2006 Aug; 13(8):799-801. PubMed ID: 16931326
    [No Abstract]   [Full Text] [Related]  

  • 55. [An advancement in drug research: rational drug design with combinatorial chemistry].
    Pindur U
    Pharm Unserer Zeit; 1997 Jan; 26(1):24-30. PubMed ID: 9157462
    [No Abstract]   [Full Text] [Related]  

  • 56. Development trends for therapeutic antibody fragments.
    Nelson AL; Reichert JM
    Nat Biotechnol; 2009 Apr; 27(4):331-7. PubMed ID: 19352366
    [No Abstract]   [Full Text] [Related]  

  • 57. High-throughput drug discovery: what can we expect from HTS?
    Gribbon P; Sewing A
    Drug Discov Today; 2005 Jan; 10(1):17-22. PubMed ID: 15676295
    [No Abstract]   [Full Text] [Related]  

  • 58. Now we are talking sense! Functional approaches to novel nutraceuticals and cosmeceuticals.
    Krohn M; Kleber A; Schaffar G; Dechert U; Eck J
    Biotechnol J; 2008 Oct; 3(9-10):1147-56. PubMed ID: 18624347
    [No Abstract]   [Full Text] [Related]  

  • 59. [Combinatorial chemistry as a pool for new drugs].
    Radau G
    Pharm Unserer Zeit; 1997 Jan; 26(1):10-1. PubMed ID: 9157459
    [No Abstract]   [Full Text] [Related]  

  • 60. Simon Campbell on the ups and downs of drug discovery and development. Interview by Jayne Carey and Samantha Barton.
    Campbell S
    Drug Discov Today; 2005 Feb; 10(4):233-6. PubMed ID: 15708739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.